Altair Technology Powers Cleveland Golf’s New HiBore XL Driver

Altair® HyperWorks® platform empowers Cleveland Golf to break free from traditional design limits Altair(Nasdaq: ALTR), a global leader in computational intelligence, announced its latest collaboration with Cleveland Golf, a leading golf equipment manufacturer, on the design of the new HiBore XL Driver. With Altair's advanced simulation and design technology, Cleveland Golf is raising the bar […]

Leyline Renewable Capital Realizes Investment in Westbridge Renewable Energy Solar Project

Leyline Renewable Capital(Leyline), a leading provider of debt capital solutions for renewable energy developers,today announced that is has successfully realized its investment in Sunnynook Solar Energy Inc. withWestbridge Renewable Energy Corp.(Westbridge), a Canadian renewable energy company listed on the TSX Venture Exchange (TSXV: WEB) and the OTCQX Best Market (OTCQX:WEGYF). https://mma.prnewswire.com/media/2519350/Leyline_Renewable_Capital_Logo.jpg Westbridge recently announcedthat it

/C O R R E C T I O N — Sky Labs/

In the news release, Sky Labs' Blood Pressure Monitoring Device Recognized for High Accuracy by the International Society of Hypertension, issued 24-Oct-2024 by Sky Labs over PR Newswire, we are advised by the company that there are updates to the content. The complete, corrected release follows: CART BP Redefines Blood Pressure Monitoring with Clinically Proven

Valvoline Inc. Reports Fourth Quarter and Fiscal Year 2024 Results

Sales of $1.6 billion and system-wide store sales of $3.1 billion each growing 12%, delivering 18th fiscal year of system-wideSSS growth Fiscal year highlights — Sales from continuing operations of $1.6 billion grew 12%, driven by system-wide same-store sales (SSS) growth of 6.7% — Store count increased nearly 9% YoY, bringing system-wide total to 2,010

CQG to Offer Day-One Connectivity to New MIAX Futures Exchange Matching Engine

CQG will Support Access to Products Available on the New MIAX Futures Exchange Onyx Trading Platform CQG, a leading global provider of high-performance technology solutions for market makers, traders, brokers, commercial hedgers and exchanges, today announced that it will offer day-one access to MIAX Futures Exchange (MIAX Futures™) – including new Bloomberg equity index futures

Caspia Announces Former Senior Vice President of Engineering from NVIDIA Joins Its Advisory Board

Brian Kelleher brings substantial knowledge of advanced chip design and AI to Caspia Technologies Caspia Technologies, a pioneer in the development of AI-enhanced hardware security verification for advancedSoCs and systems, today announced the addition of Brian Kelleher to its Advisory Board. Kelleher joins a team that includesDr. Wally Rhines, CEO of Cornami and previous CEO

George Weston Limited Reports Third Quarter 2024 Results

George Weston Limited (TSX: WN) (“GWL” or the “Company”) today announced its consolidated unaudited results for the 16 weeks ended October 5, 2024(2). GWL's 2024 Third QuarterReport has been filed on SEDAR+ and is available at www.sedarplus.ca and in the Investor Centre section of theCompany's website at www.weston.ca. “George Weston delivered another quarter of positive

GDS Holdings Limited Reports Third Quarter 2024 Results

SHANGHAI, China, Nov. 19, 2024 (GLOBE NEWSWIRE) — GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China and South East Asia, today announced its unaudited financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights

Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association

NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced that its grant application to the ALS Association has been approved for funding. The grant

Apeiron Enrolls First Patient in Phase 1a/b Study of PRMT5 Inhibitor GTA182 for MTAP-Deleted Solid Tumors

– Potentially best-in-class MTA-cooperative PRMT5 inhibitor – – First patient in for Phase 1a/b study to evaluate GTA182 clinically in patients having tumors with MTAP deletion – SAN FRANCISCO and SHANGHAI, Nov. 19, 2024 (GLOBE NEWSWIRE) — Apeiron Therapeutics (Apeiron), a precision oncology company leveraging state-of-the-art structural biology and AI-guided molecular modeling for drug discovery,

Scroll to Top